11-12 September 2018 //  Lancaster Royal Hotel, London


Miguel Forte

Miguel Forte

CEO / Managing Director; Chief Commercialisation Officer and Chair of Commercialisation Committee, Zelluna Immunotherapy / ISCT

Miguel holds a MD and a PhD in immunology, an accreditation as Specialist in Infectious Diseases, a certificate on Health Economics of Pharmaceuticals and Medical Technologies (HEP). He is Fellow of the Faculty of Pharmaceutical Medicine of the RCP (UK). After several Clinical, Academic and Regulatory positions in the Public Sector in Portugal and at the EMA he spent six years with Bristol-Myers Squibb successively as Medical Director (1998-2000), Executive Director Infectious Diseases, Immunology and Dermatology (2000-2002) and Vice-President International Medical Organization (2002-2003) in Portugal and Belgium. In 2004, Miguel joined Nabi Pharmaceuticals as Vice-President Clinical, Medical and Regulatory Affairs Europe. From February 2006 to January 2010 he was Vice-President Global Medical Affairs Inflammation Worldwide at UCB. Miguel is currently visiting Professor of the Lisbon and Aveiro Universities in Portugal, Chief Commercialisation Officer and Chair of the Commercialisation Committee of the International Society of Cellular Therapy and Chief Operating Officer and of TxCell.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad